Recruiting × Head and Neck Neoplasms × Gastrointestinal × Clear all Feasibility Study of CBCT for IGRT in Cancer Patients
Phase NA Recruiting
50 enrolled
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Phase 1/2 Recruiting
300 enrolled
MOMENTUM
Recruiting
8,000 enrolled
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care
Phase NA Recruiting
860 enrolled
A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
Phase 1 Recruiting
97 enrolled
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
Phase 2 Recruiting
24 enrolled
IDOV-Immune for Advanced Solid Tumors
Phase 1 Recruiting
78 enrolled
Virtual Rehabilitation for Cancer Survivors
Phase NA Recruiting
388 enrolled
DP-04
Recruiting
100 enrolled
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Recruiting
100 enrolled
EGRET
Phase 1 Recruiting
403 enrolled
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Phase 1 Recruiting
240 enrolled
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Phase 1 Recruiting
170 enrolled
Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
Phase 1/2 Recruiting
400 enrolled
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
Phase 1 Recruiting
216 enrolled
Improving Care for Rural Patients With Solid Tumors
Phase NA Recruiting
320 enrolled
Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
Recruiting
1,250 enrolled
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Phase 2 Recruiting
740 enrolled
CAMPERR
Recruiting
7,000 enrolled
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Phase 1/2 Recruiting
112 enrolled
ELEPHAS-05
Recruiting
2,000 enrolled
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
Phase NA Recruiting
590 enrolled
ELEPHAS-02
Recruiting
416 enrolled
AcSé HER2
Phase 2 Recruiting
105 enrolled
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Phase 1/2 Recruiting
242 enrolled
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Phase 1 Recruiting
310 enrolled
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
Phase 4 Recruiting
100 enrolled
A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
Phase 1/2 Recruiting
270 enrolled
Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
Phase 1/2 Recruiting
126 enrolled
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Phase 1/2 Recruiting
300 enrolled
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
Recruiting
700 enrolled
CAPTIV-8
Phase 2 Recruiting
200 enrolled
OvAR-Y
Recruiting
10 enrolled
Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
Recruiting
125 enrolled
DECIDE
Phase NA Recruiting
1,100 enrolled
MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
Phase 1 Recruiting
40 enrolled
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Phase 1 Recruiting
292 enrolled
PREMIER
Recruiting
500 enrolled
IC-Growth
Phase NA Recruiting
180 enrolled
ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy
Phase 2 Recruiting
70 enrolled
JUMP
Phase NA Recruiting
86 enrolled
TRIDENT-1
Phase 1/2 Recruiting
500 enrolled 2 FDA
START-001
Phase 1/2 Recruiting
365 enrolled
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Phase 2 Recruiting
51 enrolled
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Phase 1/2 Recruiting
115 enrolled
HTL0039732 in Participants With Advanced Solid Tumours
Phase 1/2 Recruiting
150 enrolled
MOIO
Phase 3 Recruiting
646 enrolled
RAPA-201 Therapy of Solid Tumors
Phase 1/2 Recruiting
37 enrolled
Brodalumab in the Treatment of Immune-Related Adverse Events
Phase 1 Recruiting
11 enrolled
99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors
Recruiting
20 enrolled